Loading...
Loading...
India's rosuvastatin imports from INDONESIA total $974 across 2 shipments from 2 foreign suppliers. PT MITRA MEDIS EXIM leads with $713 in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include TORRENT PHARMACEUTICALS LIMITED. This corridor reflects India's pharmaceutical import demand for rosuvastatin โ a concentrated sourcing relationship with select suppliers from INDONESIA.

PT MITRA MEDIS EXIM is the leading Rosuvastatin supplier from INDONESIA to India, with import value of $713 across 1 shipments. The top 5 suppliers โ PT MITRA MEDIS EXIM, M/S. PT MITRA MEDIS EXIM โ collectively account for 100.0% of total import value from this origin.
Ranked by import value (USD) ยท Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | PT MITRA MEDIS EXIM | $713 | 1 | 73.2% |
| 2 |
| M/S. PT MITRA MEDIS EXIM |
| $261 |
| 1 |
| 26.8% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | TORRENT PHARMACEUTICALS LIMITED | $713 | 1 | 73.2% |
| 2 | TORRENT PHARMACEUTICALS LTD | $261 | 1 | 26.8% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Rosuvastatin suppliers from INDONESIA to India include PT MITRA MEDIS EXIM, M/S. PT MITRA MEDIS EXIM. The leading supplier is PT MITRA MEDIS EXIM with import value of $713 USD across 1 shipments. India imported Rosuvastatin worth $974 USD from INDONESIA in total across 2 shipments.
India imported Rosuvastatin worth $974 USD from INDONESIA across 2 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Rosuvastatin sourced from INDONESIA include TORRENT PHARMACEUTICALS LIMITED, TORRENT PHARMACEUTICALS LTD. The largest buyer is TORRENT PHARMACEUTICALS LIMITED with $713 in imports across 1 shipments.
The total value of Rosuvastatin imports from INDONESIA to India is $974 USD, across 2 shipments and 2 foreign suppliers. Data source: Indian Customs (DGFT).
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records โ the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
2 Verified Shipments
2 suppliers, 2 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists